In 2023, China's share in the top-cited scientific publications in endocrinology, diabetes, and metabolism stood strong at 24.12%, reflecting a rapid growth of 31.54% year-on-year. Meanwhile, the United States maintained a significant presence with a slight increase of 1.27%. Noteworthy growth was also seen in Italy and India, which jumped 25.38% and 32.36% respectively. Indonesia's remarkable rise by 162.35% signals emerging research vitality. In contrast, some European nations like Finland and Portugal saw a slight decline.
Future trends to watch include the continued rise of Asian countries in scientific contributions, with China and India expected to further cement their positions. Additionally, innovation in diabetes and metabolic research could pivot towards countries experiencing emerging market growth, potentially reshaping global research landscapes.
- China's strong research output growth
- United States remains pivotal with moderate increases
- Italy and India's accelerating contributions
- Fast-emerging growth in Indonesia's research impact
- Western countries showing varied changes, with some declines
Top countries in Total Number of 10% Top-Cited Scientific Publications in Endocrinology, Diabetes and Metabolism Share by Country (Units (Publications))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 24.12 | 2023 | +21.57% | +31.54% | View data |
| 2 | 2 United States | 19.24 | 2023 | +0.11% | +1.27% | View data |
| 3 | 3 Italy | 13.58 | 2023 | +18.71% | +25.38% | View data |
| 4 | 4 United Kingdom | 5.67 | 2023 | +2.27% | +5.01% | View data |
| 5 | 5 India | 3.68 | 2023 | +5.98% | +32.36% | View data |
| 6 | 6 Germany | 3.08 | 2023 | +0.98% | +1.71% | View data |
| 7 | 7 Australia | 2.64 | 2023 | +2.75% | -0.52% | View data |
| 8 | 8 Canada | 2.46 | 2023 | +0.19% | +0.26% | View data |
| 9 | 9 Japan | 2.44 | 2023 | +3.59% | +3.27% | View data |
| 10 | 10 South Korea | 2.23 | 2023 | +11.5% | +0.2% | View data |
